Primary nasal chondrosarcoma. The pediatric experience

Area of Science:

• Oncology
• Pediatric Oncology
• Head and Neck Surgery

Background:

• Chondrosarcomas are rare tumors, particularly in the head and neck region, accounting for only 4% of nonepithelial tumors in the nasal cavity, paranasal sinuses, and nasopharynx.
• The peak incidence of chondrosarcoma is typically in the fourth decade of life.
• Pediatric cases of head or neck chondrosarcoma are exceptionally rare, with only four reported in children aged 10 years or younger.

Observation:

• This report focuses on a rare case of a 5-year-old boy diagnosed with chondrosarcoma of the nasal cavity.
• The patient underwent complete surgical resection of the tumor.
• Adjuvant chemotherapy was administered post-operatively.

Findings:

• This case represents one of the few documented instances of primary nasal cavity chondrosarcoma in a child under 10 years old.
• The rarity of this tumor in pediatric patients highlights the need for specialized diagnostic and treatment approaches.
• The literature review associated with this case provides further context on the epidemiology and clinical presentation of pediatric head and neck chondrosarcomas.

Implications:

• This case underscores the importance of considering rare diagnoses like chondrosarcoma in pediatric head and neck masses.
• The successful treatment of this young patient with adjuvant chemotherapy following resection suggests potential therapeutic avenues for similar rare pediatric tumors.
• Further research and case reporting are crucial for understanding and improving outcomes for pediatric chondrosarcoma in the head and neck.